The EDC is live today — see what ships now
All studies
NCT07339423From ClinicalTrials.govRecruiting

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Obesity (AMAZE 1)

  • Obesity

At a glance

Phase
Phase 3
Study type
Interventional
Sponsor
Novo Nordisk A/S
Enrolment target
1,150
Started
24 February 2026
Main results due
26 June 2029
Study sites
72
Registry updated
24 September 2026

Can you take part?

  • Aged 18 years and over.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Key Inclusion Criteria:

* Male or female (sex at birth).
* Informed consent obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study, including activities to determine suitability for the study.
* History of at least one self-reported unsuccessful dietary effort to lose body weight.

Key Exclusion Criteria:

* HbA1c ≥ 6.5% (48 millimole per mole \[mmol/mol\]) as measured by the central laboratory at screening.
* History of type 1 or type 2 diabetes mellitus as declared by the participant or reported in the medical records.
* Treatment with glucagon-like-peptide-1 (GLP-1) receptor agonists (RA), dual GLP-1/gastric inhibitory peptide (GIP) RAs (or any other GLP-1 based treatment) or amylin analogues before screening.

What this study is about

In the sponsor’s own words, from the registry.

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.

Study sites(72)

  • South Broward Research LLC

    Miramar, Florida, United States

    Recruiting

  • Clinical Neuroscience Solution

    Orlando, Florida, United States

    Recruiting

  • Hope Clin Res & Wellness

    Conyers, Georgia, United States

    Recruiting

  • Endeavor Health

    Skokie, Illinois, United States

    Recruiting

  • Midwest Inst For Clin Res

    Indianapolis, Indiana, United States

    Recruiting

  • StudyMetrix Research LLC

    City of Saint Peters, Missouri, United States

    Recruiting

  • New York Gastroenterology Associates

    New York, New York, United States

    Recruiting

  • UNC Eastowne Medical Office

    Chapel Hill, North Carolina, United States

    Recruiting

  • PharmQuest Life Sciences LLC

    Greensboro, North Carolina, United States

    Recruiting

  • Accellacare and KDCILM, LLC

    Wilmington, North Carolina, United States

    Recruiting

  • UPA Ctr Weight and Eating Dis

    Philadelphia, Pennsylvania, United States

    Recruiting

  • Clinical Res Collaborative

    Cumberland, Rhode Island, United States

    Recruiting

  • Medical Uni of SC Charleston

    Charleston, South Carolina, United States

    Recruiting

  • Coastal Carolina Research Ctr

    North Charleston, South Carolina, United States

    Recruiting

  • Hillcrest Clinical Research

    Simpsonville, South Carolina, United States

    Recruiting

  • Amarillo Medical Specialists

    Amarillo, Texas, United States

    Recruiting

  • Velocity Clinical Res-Dallas

    Dallas, Texas, United States

    Recruiting

  • Care United Research, LLC

    Forney, Texas, United States

    Recruiting

  • Washington Cntr Weight Mgmt

    Arlington, Virginia, United States

    Recruiting

  • Health Res of Hampton Roads

    Newport News, Virginia, United States

    Recruiting

  • Selma Medical Associates

    Winchester, Virginia, United States

    Recruiting

  • Rainier Clin Res Ctr Inc

    Renton, Washington, United States

    Recruiting

  • Fundación CESIM

    Santa Rosa, La Pampa Province, Argentina

    Recruiting

  • Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli

    Buenos Aires, Argentina

    Recruiting

  • Instituto de Investigaciones Clínicas Córdoba

    Córdoba, Argentina

    Recruiting

  • Sanatorio Esperanza

    Esperanza, Santa Fe, Argentina

    Recruiting

  • CIPADI

    Godoy Cruz, Argentina

    Recruiting

  • Instituto de Investigaciones Clinicas San Nicolás

    San Nicolás, Argentina

    Recruiting

  • Sydney Clinical Trials

    Campbelltown, New South Wales, Australia

    Recruiting

  • Sydney Cardiometabolic Centre

    Liverpool, New South Wales, Australia

    Recruiting

  • Hunter Diabetes Centre

    Merewether, New South Wales, Australia

    Recruiting

  • Heart of Australia

    Chelmer, Queensland, Australia

    Recruiting

  • HUB - Hôpital Erasme

    Brussels, Belgium

    Recruiting

  • UZA - UZ Antwerpen - Department of Endocrinology

    Edegem, Belgium

    Recruiting

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

    Recruiting

  • UZ Leuven - Endocrinology

    Leuven, Belgium

    Recruiting

  • MECLINAS

    Mechelen, Belgium

    Recruiting

  • AZ Delta - Roeselare

    Roeselare, Belgium

    Recruiting

  • C-Health Partners

    Calgary, Alberta, Canada

    Recruiting

  • Ocean West Research Clinic

    Surrey, British Columbia, Canada

    Recruiting

  • G.A. Research Associates Ltd.

    Moncton, New Brunswick, Canada

    Recruiting

  • Nova Scotia Hlth Halifax

    Halifax, Nova Scotia, Canada

    Recruiting

  • Milestone Research

    London, Ontario, Canada

    Recruiting

  • Sanos Clinic - Vejle

    Vejle, Region Syddanmark, Denmark

    Recruiting

  • Sanos Clinic - Gandrup

    Gandrup, Denmark

    Recruiting

  • Steno Diabetes Center Nordjylland

    Gistrup, Denmark

    Completed

  • Gentofte Hospital - Center for Klinisk Metabolisk Forskning

    Hellerup, Denmark

    Recruiting

  • Hillerød Endokrinologisk amb. H0652

    Hillerød, Denmark

    Recruiting

  • Hvidovre Hospital Endokrinologisk forsknings afsnit 159

    Hvidovre, Denmark

    Recruiting

  • HOPITAL EUROPEEN GEORGES POMPIDOU_Service de nutrition et diabétologie

    Paris, France

    Recruiting

  • HCL-HOPITAL LYON SUD_Service d'Endocrinologie-Diabète-Nutrition

    Pierre-Bénite, France

    Recruiting

  • CHU NANTES - HOPITAL NORD LAENNEC_Service d'Endocrinologie-Diabétologie-Nutrition

    Saint-Herblain, France

    Recruiting

  • CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE-HOPITAL RANGUEIL-Service de diabétologie et nutrition

    Toulouse, France

    Recruiting

  • CENTRE DE RECHERCHE CLINIQUE PORTES DU SUD_Service d'Endocrinologie-Diabétologie-Maladies Métaboliques

    Vénissieux, France

    Recruiting

  • Herz- und Diabeteszentrum NRW - Bad Oeynhausen

    Bad Oeynhausen, Germany

    Active, not recruiting

  • Zentrum für klinische Studien Südbrandenburg GmbH

    Elsterwerda, Germany

    Active, not recruiting

  • MVZ im Altstadt-Carree Fulda GmbH - Zentrum für klinische Studien

    Fulda, Germany

    Active, not recruiting

  • SMO.MD GmbH - Zentrum für klinische Studien

    Magdeburg, Germany

    Active, not recruiting

  • Institut für Diabetesforschung Osnabrück

    Osnabrück, Germany

    Active, not recruiting

  • Forschungszentrum Ruhr KliFoCenter GmbH, Kahrmann

    Witten, Germany

    Active, not recruiting

Showing 60 of 72 sites — filter to narrow it down. 65 of the 72 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07339423. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weigh | Trialion